Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC	Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma	Recruiting	Phase 2	2025-08-20		NCT05446467

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Zhejiang Provincial People's Hospital	74

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ningbo Medical Center Lihuili Hospital	Ningbo	China	11
Sir Run Run Shaw Hospital School of Medicine,Zhejiang University	Hangzhou	China	1
The Affiliated Hospital of Qingdao University	Qingdao	China	4
The First Affiliated Hospital of Wenzhou Medical University	Wenzhou	China	26
Tianjin Cancer Hospital Airport Hospital	Tianjin	China	9
Zhejiang Cancer Hospital	Hangzhou	China	40
Zhejiang Provincial People's Hospital	Hangzhou	China	48